Didanosine 1007 trihydrochloride without affecting the survival of

without affecting the survival of parental Ba/F3 cells at concentrations up to 1 μM

13 mM) Ethanol (warmed with 50ºC water bath) 3 mg/mL (10

1410880-22-6

) tumors derived from the periostin-expressing ovarian cancer cell line A2780

as a result

Didanosine 1007 trihydrochloride without affecting the survival ofDidanosine (2,3 dideoxyinosine, ddI, DDI) marketed under the trade names Videx and Videx EC. It is an antiretroviral medication used to treat HIV AIDS in combination with other medications as part of highly active antiretroviral therapy (HAART). It is of the reverse transcriptase inhibitor class. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. (Source: